Physician
Fillos, Triantafillos
Fillos, Triantafillos was paid $564K by Medicaid between Jan 2018 and Oct 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoFILLOS, TRIANTAFILLOS
BAYSIDE, NY 11361
BAYSIDE, NY 11361
33aNPI1598863458assigned 09/21/2006
33bProvider typeHematology & Oncology Physician
28Total paid$564K
24GClaims29,738
24DCodes billed36
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in New York
Rank by total paid#24 of 441
Median peer was paid$9K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,821 | $41K | |
| 2019 | 3,805 | $66K | |
| 2020 | 4,734 | $73K | |
| 2021 | 6,393 | $145K | |
| 2022 | 6,359 | $115K | |
| 2023 | 5,102 | $87K | |
| 2024incomplete | 1,524 | $36K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 4,587 | 4,321 | $224K |
| 99205 | Prolong outpt/office vis | 8.7% | 401 | 400 | $49K |
| 88185 | 6.4% | 108 | 108 | $36K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 5.9% | 71 | 51 | $33K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.5% | 674 | 644 | $31K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.0% | 645 | 409 | $28K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.4% | 548 | 346 | $19K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.0% | 309 | 294 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 4,185 | 3,448 | $16K |
| 80053 | Comprehensive metabolic panel | 2.6% | 2,541 | 2,314 | $15K |
| 82728 | 2.1% | 1,273 | 1,260 | $12K | |
| 82607 | 2.1% | 1,080 | 1,075 | $12K |
24 more codes
| 82746 | 1.8% | 1,006 | $10K | |
| 99490 | Ccm add 20min | 1.6% | 933 | $9K |
| 83615 | 1.4% | 2,084 | $8K | |
| 83550 | 1.3% | 1,219 | $7K | |
| 83540 | <1% | 1,255 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 945 | $5K |
| 88184 | <1% | 108 | $4K | |
| 84550 | <1% | 1,117 | $3K | |
| 84100 | <1% | 803 | $3K | |
| 83735 | <1% | 589 | $3K | |
| 83010 | <1% | 262 | $2K | |
| 85044 | <1% | 779 | $2K | |
| 96367 | <1% | 101 | $2K | |
| 86334 | <1% | 85 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,575 | $1K |
| 82784 | <1% | 59 | $1K | |
| 84165 | <1% | 86 | $871.10 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 46 | $683.68 |
| 82378 | <1% | 41 | $420.84 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 39 | $347.35 |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 25 | $292.70 |
| 80050 | General health panel | <1% | 12 | $193.05 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 109 | $41.95 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.